相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Progranulin Gene Therapy Improves Lysosomal Dysfunction and Microglial Pathology Associated with Frontotemporal Dementia and Neuronal Ceroid Lipofuscinosis
Andrew E. Arrant et al.
JOURNAL OF NEUROSCIENCE (2018)
Longitudinal In Vivo Monitoring of the CNS Demonstrates the Efficacy of Gene Therapy in a Sheep Model of CLN5 Batten Disease
Nadia L. Mitchell et al.
MOLECULAR THERAPY (2018)
Prevention of Photoreceptor Cell Loss in a Cln6(nclf) Mouse Model of Batten Disease Requires CLN6 Gene Transfer to Bipolar Cells
Sophia-Martha Kleine Holthaus et al.
MOLECULAR THERAPY (2018)
Study of Intraventricular Cerliponase Alfa for CLN2 Disease
Angela Schulz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study
Miriam Nickel et al.
LANCET CHILD & ADOLESCENT HEALTH (2018)
Extraneuronal pathology in a canine model of CLN2 neuronal ceroid lipofuscinosis after intracerebroventricular gene therapy that delays neurological disease progression
M. L. Katz et al.
GENE THERAPY (2017)
Fingolimod and Teriflunomide Attenuate Neurodegeneration in Mouse Models of Neuronal Ceroid Lipofuscinosis
Janos Groh et al.
MOLECULAR THERAPY (2017)
Management Strategies for CLN2 Disease
Ruth E. Williams et al.
PEDIATRIC NEUROLOGY (2017)
Synergistic effects of treating the spinal cord and brain in CLN1 disease
Charles Shyng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases
Michela Palmieri et al.
NATURE COMMUNICATIONS (2017)
Cerliponase Alfa: First Global Approval
Anthony Markham
DRUGS (2017)
Fibrates inhibit the apoptosis of Batten disease lymphoblast cells via autophagy recovery and regulation of mitochondrial membrane potential
Minho Hong et al.
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL (2016)
Efficacy of Phosphodiesterase-4 Inhibitors in Juvenile Batten Disease (CLN3)
Amy Aldrich et al.
ANNALS OF NEUROLOGY (2016)
The awesome lysosome
Andrea Ballabio
EMBO MOLECULAR MEDICINE (2016)
Intravitreal implantation of TPP1-transduced stem cells delays retinal degeneration in canine CLN2 neuronal ceroid lipofuscinosis
Christopher J. Tracy et al.
EXPERIMENTAL EYE RESEARCH (2016)
Sialoadhesin promotes neuroinflammation-related disease progression in two mouse models of CLN disease
Janos Groh et al.
GLIA (2016)
Using Patient-Specific Induced Pluripotent Stem Cells and Wild-Type Mice to Develop a Gene Augmentation-Based Strategy to Treat CLN3-Associated Retinal Degeneration
Luke A. Wiley et al.
HUMAN GENE THERAPY (2016)
Self-Complementary AAV9 Gene Delivery Partially Corrects Pathology Associated with Juvenile Neuronal Ceroid Lipofuscinosis (CLN3)
Megan E. Bosch et al.
JOURNAL OF NEUROSCIENCE (2016)
Activation of Peroxisome Proliferator-activated Receptor α Induces Lysosomal Biogenesis in Brain Cells IMPLICATIONS FOR LYSOSOMAL STORAGE DISORDERS
Arunava Ghosh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Intrathecal enzyme replacement therapy improves motor function and survival in a preclinical mouse model of infantile neuronal ceroid lipofuscinosis
Jui-Yun Lu et al.
MOLECULAR GENETICS AND METABOLISM (2015)
AAV gene transfer delays disease onset in a TPP1-deficient canine model of the late infantile form of Batten disease
Martin L. Katz et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Sustained Neural Stem Cell-Based Intraocular Delivery of CNTF Attenuates Photoreceptor Loss in the nclf Mouse Model of Neuronal Ceroid Lipofuscinosis
Wanda Jankowiak et al.
PLOS ONE (2015)
Enzyme replacement therapy delays pupillary light reflex deficits in a canine model of late infantile neuronal ceroid lipofuscinosis
Rebecca E. H. Whiting et al.
EXPERIMENTAL EYE RESEARCH (2014)
Partial Correction of the CNS Lysosomal Storage Defect in a Mouse Model of Juvenile Neuronal Ceroid Lipofuscinosis by Neonatal CNS Administration of an Adeno-Associated Virus Serotype rh. 10 Vector Expressing the Human CLN3 Gene
Dolan Sondhi et al.
HUMAN GENE THERAPY (2014)
Human iPSC models of neuronal ceroid lipofuscinosis capture distinct effects of TPP1 and CLN3 mutations on the endocytic pathway
Xenia Lojewski et al.
HUMAN MOLECULAR GENETICS (2014)
An Anti-Neuroinflammatory That Targets Dysregulated Glia Enhances the Efficacy of CNS-Directed Gene Therapy in Murine Infantile Neuronal Ceroid Lipofuscinosis
Shannon L. Macauley et al.
JOURNAL OF NEUROSCIENCE (2014)
Enzyme Replacement Therapy Attenuates Disease Progression in a Canine Model of Late-Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)
Martin L. Katz et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2014)
Oral cysteamine bitartrate and N-acetylcysteine for patients with infantile neuronal ceroid lipofuscinosis: a pilot study
Sondra W. Levin et al.
LANCET NEUROLOGY (2014)
Immune cells perturb axons and impair neuronal survival in a mouse model of infantile neuronal ceroid lipofuscinosis
Janos Groh et al.
BRAIN (2013)
Chronic oral administration of minocycline to sheep with ovine CLN6 neuronal ceroid lipofuscinosis maintains pharmacological concentrations in the brain but does not suppress neuroinflammation or disease progression
Graham W. Kay et al.
JOURNAL OF NEUROINFLAMMATION (2013)
Central nervous system stem cell transplantation for children with neuronal ceroid lipofuscinosis
Nathan R. Selden et al.
JOURNAL OF NEUROSURGERY-PEDIATRICS (2013)
Neuroprotection and lifespan extension in Ppt1-/- mice by NtBuHA: therapeutic implications for INCL
Chinmoy Sarkar et al.
NATURE NEUROSCIENCE (2013)
Progressive Retinal Degeneration and Glial Activation in the CLN6nclf Mouse Model of Neuronal Ceroid Lipofuscinosis: A Beneficial Effect of DHA and Curcumin Supplementation
Myriam Mirza et al.
PLOS ONE (2013)
Synergistic effects of central nervous system-directed gene therapy and bone marrow transplantation in the murine model of infantile neuronal ceroid lipofuscinosis
Shannon L. Macauley et al.
ANNALS OF NEUROLOGY (2012)
Gemfibrozil and Fenofibrate, Food and Drug Administration-approved Lipid-lowering Drugs, Up-regulate Tripeptidyl-peptidase 1 in Brain Cells via Peroxisome Proliferator-activated Receptor α IMPLICATIONS FOR LATE INFANTILE BATTEN DISEASE THERAPY
Arunava Ghosh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Combination small molecule PPT1 mimetic and CNS-directed gene therapy as a treatment for infantile neuronal ceroid lipofuscinosis
Marie S. Roberts et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2012)
Intravenous high-dose enzyme replacement therapy with recombinant palmitoyl-protein thioesterase reduces visceral lysosomal storage and modestly prolongs survival in a preclinical mouse model of infantile neuronal ceroid lipofuscinosis
Jie Hu et al.
MOLECULAR GENETICS AND METABOLISM (2012)
New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses
Ruth E. Williams et al.
NEUROLOGY (2012)
Age-dependent therapeutic effect of memantine in a mouse model of juvenile Batten disease
Attila D. Kovacs et al.
NEUROPHARMACOLOGY (2012)
Long-Term Expression and Safety of Administration of AAVrh.10hCLN2 to the Brain of Rats and Nonhuman Primates for the Treatment of Late Infantile Neuronal Ceroid Lipofuscinosis
Dolan Sondhi et al.
HUMAN GENE THERAPY METHODS (2012)
Immunosuppression alters disease severity in juvenile Batten disease mice
Sabrina S. Seehafer et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Analysis of Potential Biomarkers and Modifier Genes Affecting the Clinical Course of CLN3 Disease
Anne-Helene Lebrun et al.
MOLECULAR MEDICINE (2011)
Temporary inhibition of AMPA receptors induces a prolonged improvement of motor performance in a mouse model of juvenile Batten disease
Attila D. Kovacs et al.
NEUROPHARMACOLOGY (2011)
CNS-Expressed Cathepsin D Prevents Lymphopenia in a Murine Model of Congenital Neuronal Ceroid Lipofuscinosis
Zinayida Shevtsova et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Neuroprotection of Host Cells by Human Central Nervous System Stem Cells in a Mouse Model of Infantile Neuronal Ceroid Lipofuscinosis
Stanley J. Tamaki et al.
CELL STEM CELL (2009)
Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA
Stefan Worgall et al.
HUMAN GENE THERAPY (2008)
Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis
Michael Chang et al.
MOLECULAR THERAPY (2008)
Selectively increased sensitivity of cerebellar granule cells to AMPA receptor-mediated excitotoxicity in a mouse model of Batten disease
Attila D. Kovacs et al.
NEUROBIOLOGY OF DISEASE (2006)
Intracranial delivery of CLN2 reduces brain pathology in a mouse model of classical late infantile neuronal ceroid lipofuscinosis
MA Passini et al.
JOURNAL OF NEUROSCIENCE (2006)
Embryonic stem cell-derived neural progenitors incorporate into degenerating retina and enhance survival of host photoreceptors
Jason S. Meyer et al.
STEM CELLS (2006)
AAV2-Mediated ocular gene therapy for infantile neuronal ceroid lipofuscinosis
M Griffey et al.
MOLECULAR THERAPY (2005)
Adeno-associated virus 2-mediated gene therapy decreases autofluorescent storage material and increases brain mass in a murine model of infantile neuronal ceroid lipofuscinosis
M Griffey et al.
NEUROBIOLOGY OF DISEASE (2004)
An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease
S Chattopadhyay et al.
HUMAN MOLECULAR GENETICS (2002)
Lysosomal ceroid depletion by drugs: Therapeutic implications for a hereditary neurodegenerative disease of childhood
ZJ Zhang et al.
NATURE MEDICINE (2001)
分享论文
